CLARIVATE Deferred Long Term Liab from 2010 to 2026
| CLVT Stock | USD 2.44 -0.13 -5.06% |
Deferred Long Term Liabilities | First Reported 2010-06-30 | Previous Quarter 313.6 M | Current Value 262.1 M | Quarterly Volatility 144.4 M |
CLARIVATE | Deferred Long Term Liab | Build AI portfolio with CLARIVATE Stock |
Latest CLARIVATE PLC's Deferred Long Term Liab Growth Pattern
| Deferred Long Term Liab | 10 Years Trend |
|
Deferred Long Term Liab |
| Timeline |
CLARIVATE Deferred Long Term Liab Regression Statistics
| Arithmetic Mean | 157,396,162 | |
| Geometric Mean | 67,406,647 | |
| Coefficient Of Variation | 104.16 | |
| Mean Deviation | 155,410,543 | |
| Median | 31,879,000 | |
| Standard Deviation | 163,947,924 | |
| Sample Variance | 26878.9T | |
| Range | 376.2M | |
| R-Value | 0.83 | |
| Mean Square Error | 8757.2T | |
| R-Squared | 0.69 | |
| Significance | 0.000033 | |
| Slope | 27,057,689 | |
| Total Sum of Squares | 430062.7T |
CLARIVATE Deferred Long Term Liab History
Stock Overview, Methodology & Data Sources
Methodology
Unless otherwise specified, financial data for CLARIVATE PLC is derived from periodic company reporting (annual and quarterly where available). Asset-level metrics are computed daily by Macroaxis LLC and refreshed regularly based on asset type. CLARIVATE (USA Stocks:CLVT) prices are typically delayed by approximately 20 minutes from primary exchanges for listed equities. Data may be delayed depending on reporting sources and market conventions. Assumptions: We primarily rely on public filings and market reference sources, including disclosures published by U.S. Securities and Exchange Commission (SEC) via EDGAR. Data is normalized for analytical consistency across reporting formats. All analytics are generated using standardized, rules-based models designed to promote consistency and comparability across instruments. Model assumptions, reference parameters, and selected computational inputs are available in the Model Inputs section. If you have questions about our data sources or methodology, please contact Macroaxis Support.
Analyst Sources
CLARIVATE PLC has active sell-side coverage. Source-validated coverage currently shows 9 approved analysts, while broader market-consensus totals may differ across providers due to methodology and update timing. 4 analysts have submitted revenue and/or earnings estimates that may be incorporated into Macroaxis consensus inputs where available. Representative analyst firms may include Citigroup, UBS Investment Research, Oppenheimer & Co., Raymond James, Bank of America Securities, Wells Fargo Securities, among others. Updates may occur throughout the day.
This content is curated and reviewed by:
Ellen Johnson - Member of Macroaxis Editorial BoardThematic Opportunities
Explore Investment Opportunities
Additional Tools for CLARIVATE Stock Analysis
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences |